(reported by the Company)
No items found
Medibio Limited (ASX:MEB) is an Australian listed company focused on the validation and commercialisation of its exciting new circadian heart rate variability technology acquired via the acquisition of Invatec Health. After a decade of research and development based on more than 5,000 patients, the company is now planning trials to support regulatory approval of the CRV diagnostic for depression and other mental illnesses.
Medibio has some legacy assets in the human health, personal care, animal health and nutrition and agricultural sectors, and holds an investment in Frontier Oil Corporation, a Philippines-based oil and gas explorer.
|Category:||Health & biotech|
|ASX Listing Code (if applicable):||MEB|
|Year of Commencement:||1987|
Suite 605, Level 6 50 Clarence Street